Narrow Results By
CMA response to patented medicines regulations consultations
https://policybase.cma.ca/link/policy13690
CMA's Response to Health Canada's Public Consultation Guide to New Authorities in reference to Bill C-17, Protecting Canadians from Unsafe Drugs Act (Vanessa's Law)
https://policybase.cma.ca/link/policy11599
Consultation on proposed front-of-package labelling
https://policybase.cma.ca/link/policy13882
- Date
- 2018-04-23
- Topics
- Health care and patient safety
- Pharmaceuticals, prescribing, cannabis, drugs
Consultation on the prescription drug list: Naloxone
https://policybase.cma.ca/link/policy11847
Consultation on the renewal of Federal Tobacco Control Strategy
https://policybase.cma.ca/link/policy13804
- Date
- 2017-04-05
- Topics
- Health care and patient safety
- Pharmaceuticals, prescribing, cannabis, drugs
Excise duty framework for cannabis products
https://policybase.cma.ca/link/policy13799
Health Canada consultation on Canadian drugs and substances strategy
https://policybase.cma.ca/link/policy14017
- Date
- 2018-12-04
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
- Population health, health equity, public health
- Policy Type
- Response to consultation
- Date
- 2018-12-04
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
- Population health, health equity, public health
Documents
Health Canada consultation on edible cannabis, extracts & topicals
https://policybase.cma.ca/link/policy14020
- Date
- 2019-02-20
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
- Population health, health equity, public health
- Policy Type
- Response to consultation
- Date
- 2019-02-20
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
- Population health, health equity, public health
Documents
Health Canada consultation on reducing youth access and appeal of vaping products
https://policybase.cma.ca/link/policy14078
- Date
- 2019-05-24
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
- Population health, health equity, public health
- Policy Type
- Response to consultation
- Date
- 2019-05-24
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
- Population health, health equity, public health
Documents
Health Canada consultation on regulatory amendments regarding tramadol
https://policybase.cma.ca/link/policy13927
Health Canada consultation on restriction of marketing and advertising of opioids
https://policybase.cma.ca/link/policy13921
Health Canada consultation on tobacco products regulations (plain and standardized appearance)
https://policybase.cma.ca/link/policy13930
- Date
- 2018-09-06
- Topics
- Health care and patient safety
- Pharmaceuticals, prescribing, cannabis, drugs
Health Canada’s Consultation on “Plain and Standardized Packaging”
https://policybase.cma.ca/link/policy13817
- Date
- 2016-08-12
- Topics
- Health care and patient safety
- Pharmaceuticals, prescribing, cannabis, drugs
Implementation of National Pharmacare
https://policybase.cma.ca/link/policy13933
- Date
- 2018-10-02
- Topics
- Health care and patient safety
- Pharmaceuticals, prescribing, cannabis, drugs
Legalization, regulation and restriction of access to marijuana
https://policybase.cma.ca/link/policy11954
Non-prescription availability of low-dose codeine products
https://policybase.cma.ca/link/policy13734
Proposed amendments to the marihuana for medical purposes regulations
https://policybase.cma.ca/link/policy11293
Proposed approach to the regulation of cannabis
https://policybase.cma.ca/link/policy13838
Regulation of Self-Care Products in Canada
https://policybase.cma.ca/link/policy13802
- Date
- 2016-10-31
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
- Health care and patient safety
Regulatory framework for the mandatory reporting of adverse drug reactions and medical device incidents by provincial and territorial healthcare institutions.
https://policybase.cma.ca/link/policy11814
- Date
- 2016-01-20
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
- Health care and patient safety